Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children

[1]  S. Myung,et al.  Efficacy of Vitamin D Supplements in Prevention of Acute Respiratory Infection: A Meta-Analysis for Randomized Controlled Trials , 2022, Nutrients.

[2]  A. Palamara,et al.  Prevention of recurrent respiratory infections , 2021, Italian Journal of Pediatrics.

[3]  Marcus H. Jones,et al.  Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement from the World Association of Infectious Diseases and Immunological Disorders (WAidid) , 2020, Microorganisms.

[4]  David A. Jolliffe,et al.  Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials , 2020, medRxiv.

[5]  Luisa Fernanda,et al.  Estimación de costo-enfermedad por neumonía y bronquiolitis en niños menores de 5 años en Colombia , 2020 .

[6]  B. Del-Río-Navarro,et al.  Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers , 2019, Health Economics Review.

[7]  Antonio J. Berlanga-Taylor,et al.  Importance of vitamin D in acute and critically ill children with subgroup analyses of sepsis and respiratory tract infections: a systematic review and meta-analysis , 2019, BMJ Open.

[8]  D. Murdoch,et al.  Global childhood pneumonia: the good news, the bad news, and the way ahead. , 2019, The Lancet. Global health.

[9]  I. Rudan,et al.  Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis , 2018, The Lancet. Global health.

[10]  A. Comellas,et al.  Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial , 2017, BMJ Open Respiratory Research.

[11]  David A. Jolliffe,et al.  Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data , 2017, British Medical Journal.

[12]  K. Jat.  Vitamin D deficiency and lower respiratory tract infections in children: a systematic review and meta-analysis of observational studies , 2017, Tropical doctor.

[13]  R. Ravasio.  Economic Analysis of the Immunostimulant OM-85 for the Prevention of Paediatric Recurrent Upper Respiratory Tract Infections , 2015, Global and Regional Health Technology Assessment.

[14]  Taixiang Wu,et al.  Probiotics for preventing acute upper respiratory tract infections , 2015, The Cochrane database of systematic reviews.

[15]  Songming Huang,et al.  Vitamin D supplementation and risk of respiratory tract infections: A meta-analysis of randomized controlled trials , 2013, Scandinavian journal of infectious diseases.

[16]  J. Lindh,et al.  Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2013, PloS one.

[17]  John H. White,et al.  Vitamin D Induces Interleukin-1β Expression: Paracrine Macrophage Epithelial Signaling Controls M. tuberculosis Infection , 2013, PLoS pathogens.

[18]  M. Drummond,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, The European Journal of Health Economics.

[19]  M. Drummond,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[20]  D. Saxena,et al.  Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis , 2012, Journal of pharmacology & pharmacotherapeutics.

[21]  C. Hawrylowicz,et al.  The role of 1α,25‐dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+and IL‐10+ CD4+ T cells , 2012, European journal of immunology.

[22]  A. Carroll,et al.  Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. , 2009, The Journal of pediatrics.

[23]  T. Kawamura,et al.  Cost-effectiveness of gargling for the prevention of upper respiratory tract infections , 2008, BMC health services research.

[24]  K. Shen,et al.  Broncho‐Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta‐analysis , 2018, International immunopharmacology.

[25]  B. Arnould,et al.  Prevention of recurrent rhinopharyngitis in at-risk children in France , 2012, PharmacoEconomics.

[26]  Z. Bhutta,et al.  Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. , 2010, The Cochrane database of systematic reviews.

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[28]  S. Zagar,et al.  Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial. , 1988, ORL; journal for oto-rhino-laryngology and its related specialties.